4//SEC Filing
Durbin Scott 4
Accession 0001437749-19-002144
CIK 0000879682other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 3:52 PM ET
Size
4.8 KB
Accession
0001437749-19-002144
Insider Transaction Report
Form 4
Durbin Scott
Chief Financial Officer
Transactions
- Award
Common Stock
2019-01-29+62,250→ 73,818 total
Footnotes (1)
- [F1]The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan (the "Plan") and received a restricted stock award of 62,250 shares of common stock on January 29, 2019 (the "Grant Date"). The restricted stock award shall vest in full upon the FDA approval of the Viveve System for improvement of sexual function or stress urinary incontinence (SUI) in the United States.
Documents
Issuer
VIVEVE MEDICAL, INC.
CIK 0000879682
Entity typeother
Related Parties
1- filerCIK 0001493500
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 3:52 PM ET
- Size
- 4.8 KB